M. Sulecki

Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Kenneth A. Foon, Michael Boyiadzis, Stephanie R. Land et al. · Journal of Clinical Oncology · 2008 · 176 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia

Kenneth A. Foon, Dhaval Mehta, Suzanne Lentzsch et al. · Blood · 2012 · 51 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Comparison of intravenous versus subcutaneous recombinant human granulocyte-macrophage colony-stimulating factor in patients with primary myelodysplasia.

C. S. Rosenfeld, M. Sulecki, C. H. Evans et al. · PubMed · 1991 · 41 citations

Life Sciences, Hematology, Immunology +7

Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours

Hussein Tawbi, Liza C. Villaruz, Ahmad A. Tarhini et al. · British Journal of Cancer · 2011 · 36 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508)

Athanassios Argiris, Ju‐Whei Lee, James Stevenson et al. · Annals of Oncology · 2017 · 19 citations · Full text

Medicine, Oncology, Pharmacology +16